Jones, Ian

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

Tie, J., Wang, Y., Tomasetti, C., Li, L., Springer, S., Kinde, I., Silliman, N., Tacey, M., Wong, H.-L., Christie, M., et al. (2016) · Science Translational Medicine

Cancer Genomics and DiagnosticsColorectal Cancer Treatments and Studies

Cited by 1,492

Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

Tie, J., Cohen, J. D., Wang, Y., Christie, M., Simons, K., Lee, M., Wong, R., Kosmider, S., Ananda, S., McKendrick, J., et al. (2019) · JAMA Oncology

Cancer Genomics and DiagnosticsColorectal Cancer Treatments and Studies

Cited by 668

Lymphocytic response to tumour and deficient dna mismatch repair identify subtypes of stage ii/iii colorectal cancer associated with patient outcomes

Williams, D. S., Mouradov, D., Jorissen, R. N., Newman, M. R., Amini, E., Nickless, D. K., Teague, J. A., Fang, C. G., Palmieri, M., Parsons, M. J., et al. (2019) · Gut

Genetic factors in colorectal cancerColorectal Cancer Treatments and Studies

Cited by 79